Overview

Duration of Use of Highly Effective Reversible Contraception

Status:
Completed
Trial end date:
2016-03-28
Target enrollment:
Participant gender:
Summary
To assess the proportion of women who use HERC for ≥2 years of duration
Details
Lead Sponsor:
Bayer
Collaborator:
University of Utah
Treatments:
Etonogestrel
Levonorgestrel